A Digital Workflow for Automated Assessment of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma Using QuPath and a StarDist-Based Model
Pathologica · 2024
DOI: 10.32074/1591-951x-1069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathologica, 2024. Verfasst von Angela Crispino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Biomedical Sciences, Pathology Unit, University of Naples "Federico II", Naples, Italy. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Mouth Neoplasms, Workflow, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Advanced Biomedical Sciences, Pathology Unit, University of Naples "Federico II", Naples, Italy.
- Department of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy.
Zitieren
APA
Crispino, A., Varricchio, S., Ilardi, G., Russo, D., Di Crescenzo, R. M., Staibano, S., & Merolla, F. (2024). A Digital Workflow for Automated Assessment of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma Using QuPath and a StarDist-Based Model. Pathologica. https://doi.org/10.32074/1591-951x-1069
Vancouver
Crispino A, Varricchio S, Ilardi G, Russo D, Di Crescenzo RM, Staibano S, et al. A Digital Workflow for Automated Assessment of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma Using QuPath and a StarDist-Based Model. Pathologica. 2024. doi:10.32074/1591-951x-1069
BibTeX
@article{Crispino2024,
author = {Crispino, Angela and Varricchio, Silvia and Ilardi, Gennaro and Russo, Daniela and Di Crescenzo, Rosa Maria and Staibano, Stefania and Merolla, Francesco},
title = {A Digital Workflow for Automated Assessment of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma Using QuPath and a StarDist-Based Model},
journal = {Pathologica},
year = {2024},
doi = {10.32074/1591-951x-1069}
}
EUVIMED